Gilead says early results of coronavirus drug trial show improvement with shorter remdesivir treatment – CNBC

0
290
Gilead says early results of coronavirus drug trial show improvement with shorter remdesivir treatment – CNBC

Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here